X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
multiple sclerosis (8) 8
humans (7) 7
female (6) 6
adult (5) 5
index medicus (5) 5
male (5) 5
middle aged (5) 5
clinical neurology (4) 4
multiple sclerosis, relapsing-remitting - drug therapy (4) 4
adolescent (3) 3
drug therapy (3) 3
glatiramer acetate (3) 3
neurology (3) 3
neurosciences (3) 3
treatment outcome (3) 3
young adult (3) 3
abridged index medicus (2) 2
adjuvants, immunologic - administration & dosage (2) 2
adjuvants, immunologic - adverse effects (2) 2
administration, cutaneous (2) 2
aged (2) 2
alemtuzumab (2) 2
antibodies, monoclonal, humanized (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
care and treatment (2) 2
disability (2) 2
functional composite (2) 2
health aspects (2) 2
immunoglobulins, intravenous - therapeutic use (2) 2
infusions, intravenous (2) 2
interferon (2) 2
interferon-beta (2) 2
internal medicine (2) 2
medicine, general & internal (2) 2
multiple sclerosis - diagnosis (2) 2
multiple-sclerosis (2) 2
peptides (2) 2
recurrence (2) 2
research (2) 2
1st demyelinating event (1) 1
acoustic stimulation (1) 1
acute brain-injury (1) 1
adjuvants, immunologic (1) 1
administration, oral (1) 1
antibodies, monoclonal (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - pharmacology (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibody (1) 1
aquaporin 4 (1) 1
aquaporin-4 (1) 1
aquaporins (1) 1
astrocytic damage (1) 1
auditory threshold - physiology (1) 1
autoimmunity (1) 1
azathioprine (1) 1
azathioprine - pharmacology (1) 1
azathioprine - therapeutic use (1) 1
bg-12 (1) 1
biomarker (1) 1
biomarkers - blood (1) 1
biomedical research (1) 1
brain stem - physiopathology (1) 1
brain-stem (1) 1
brain-stem auditory evoked potentials (1) 1
campath-1h (1) 1
cerebrospinal fluid (1) 1
cerebrospinal-fluid (1) 1
clinical trials (1) 1
clinical-trial (1) 1
clinically isolated syndromes (1) 1
cohort studies (1) 1
compensation (1) 1
complications and side effects (1) 1
crotonates - administration & dosage (1) 1
database (1) 1
deafness (1) 1
deafness - diagnosis (1) 1
deafness - physiopathology (1) 1
demography (1) 1
diagnostic-criteria (1) 1
differential diagnosis (1) 1
disability scale (1) 1
disease (1) 1
disease-free survival (1) 1
dominance, cerebral - physiology (1) 1
dosage and administration (1) 1
double-blind (1) 1
double-blind method (1) 1
drug dosages (1) 1
efficacy (1) 1
electroencephalography (1) 1
enzyme-linked immunosorbent assay (1) 1
epidemiological studies (1) 1
europe (1) 1
evoked potentials (1) 1
evoked potentials, auditory (1) 1
experimental autoimmune encephalomyelitis (1) 1
fees & charges (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 11/2012, Volume 380, Issue 9856, pp. 1829 - 1839
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9856, pp. 1819 - 1828
Journal Article
Journal of Neurology, ISSN 0340-5354, 9/2004, Volume 251, Issue 9, pp. 1138 - 1139
Byline: Christian Confavreux (1,2) Author Affiliation: (1) European Database for Multiple Sclerosis (EDMUS) Coordinating Center, Service de Neurologie A and... 
Medicine | Pregnancy | Immunoglobulins, Intravenous - therapeutic use | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Immunoglobulins, Intravenous - adverse effects | Female | Secondary Prevention | Infant, Newborn | Pregnancy Complications - drug therapy | Multiple sclerosis | Research | Health aspects
Journal Article
Brain, ISSN 0006-8950, 12/2006, Volume 129, Issue 12, p. e57
Journal Article
Brain, ISSN 0006-8950, 03/2006, Volume 129, Issue 3, p. 595
  Many efforts have been devoted to the description of the prognosis of multiple sclerosis and its possible influential factors in terms of time to reach... 
Journal Article
Journal of Neurology, ISSN 0340-5354, 10/2008, Volume 255, Issue 10, pp. 1449 - 1463
This review updates and extends earlier Consensus Reports related to current basic and escalating immunomodulatory treatments in multiple sclerosis (MS). The... 
Multiple Sclerosis | Neurology | randomized trials | Neurosciences | Medicine & Public Health | glatirameracetate | treatment escalation | interferon β | immunotherapy | Neuroradiology | monoclonal antibodies | Treatment escalation | Glatirameracetate | Interferon β | Multiple sclerosis | Randomized trials | Immunotherapy | Monoclonal antibodies | interferon beta | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | NEUTRALIZING ANTIBODIES | CLINICAL NEUROLOGY | 1ST DEMYELINATING EVENT | GLATIRAMER ACETATE COPAXONE(R) | INTERFERON-BETA THERAPY | DOUBLE-BLIND | INTRAVENOUS IMMUNOGLOBULIN TREATMENT | PLACEBO-CONTROLLED TRIAL | CLINICALLY ISOLATED SYNDROMES | MITOXANTRONE-INDUCED CARDIOTOXICITY | Azathioprine - therapeutic use | Multiple Sclerosis - diagnosis | Natalizumab | Humans | Antibodies, Monoclonal - adverse effects | Health Planning Guidelines | Glatiramer Acetate | Antibodies, Monoclonal - therapeutic use | Interferon-beta - therapeutic use | Antibodies, Monoclonal, Humanized | Societies - standards | Mitoxantrone - therapeutic use | Antibodies, Monoclonal - pharmacology | Europe | Immunologic Factors - administration & dosage | Azathioprine - pharmacology | Immunoglobulins, Intravenous - pharmacology | Multiple Sclerosis - therapy | Peptides - pharmacology | Plasmapheresis | Randomized Controlled Trials as Topic | Magnetic Resonance Imaging | Immunoglobulins, Intravenous - therapeutic use | Interferon-beta - pharmacology | Mitoxantrone - pharmacology | Peptides - therapeutic use | Immunologic Factors - therapeutic use | Care and treatment | Health aspects | Patient outcomes
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.